The ASAM Review Course in Addiction Medicine 2017 (20.5 CME)

4.57 (7 votes)

  • Registration Closed

Overview

The ASAM Review Course in Addiction Medicine is widely recognized as the essential primer for physicians and clinicians preparing for a career in addiction medicine, as well as for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

The course offers two and a half days of sessions which are mapped to the addiction medicine exam blueprint of topics for the exam and features an outstanding faculty. Over 800 professionals attend this popular course each time it is offered. ASAM’s Review Course has had a major impact on advancing a common base of scientific knowledge among physicians and other healthcare professionals.

Learning Objectives:

Upon completion, participants should be able to:

  • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse


The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

The ASAM CME Committee and Reviewers Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO, Chair

None

 

 

Catherine Friedman, MD

Vice Chair

None

 

  

Noel Ilogu, MD, MRCP, DFASAM

None

 

 

Hebert L. Malinoff, MD, FACP, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

John C. Tanner, DO, DABAM, DFASAM, CCFC, MRO

Indivior

BDSI

Honorarium

Honorarium

Speaker

Consultant/Speaker

 

The ASAM Review Course Program Planning Committee Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

 

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, INC

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

 

Stock Owned through IRA Rollover Account

Stock Owned through IRA Rollover Account

Stock Options

(Spouse)

 

Bonds in IRA

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Erin Zerbo, MD

None

 

 

 

The ASAM Review Course Faculty Member Disclosure Listing

Name

Commercial Interest

What was received?

For what role?

Petros Levounis, MD, MD, DFASAM

None

 

 

Abigail Herron, DO, DFASAM, FAPA

None

 

 

Timothy K. Brennan, MD, MPH, FASAM

None

 

 

Jeffrey DeVido, MD, MTS

Philip Morris

 

 

Altria

Ownership Interest

 

Ownership Interest

Equity Shareholder

 

Equity Shareholder

Paul H. Earley, MD, DFASAM

Alkermes

 

Georgia PHP, INC

 

Earley Counsultancy, LLC

 

DynamiCare Health, INC

Honoraria

 

Salary

 

 

Salary

 

 

 

Salary

Speaker

 

Medical Director

 

 

Principal

 

 

 

Speaker

James W. Finch, MD, DFASAM

Orexo Pharmaceuticals

 

Indivior Pharmaceuticals

Honoraria

 

 

Honoraria

Speaker

 

 

Speaker

Marc Fishman, MD, DFASAM

Alkermes

 

 

US WorldMeds

 

 

 

 

MediaRez

Salary

 

 

Salary

 

 

 

 

Research Funding

Consultant; Advisory Board

 

Consultant; Advisory Board; Principal Research Investigator

 

Principal Research Investigator

David Galbis-Reig, MD, DFASAM

Abbot Pharmaceuticals

 

AbbVie

 

 

Cortex Pharmaceuticals

GW Pharmaceuticals

 

Hospira

 

 

Pfizer, Inc

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Ownership Interest

 

Ownership Interest

 

Ownership Interest

Stock Options

 

 

Stock Options

(spouse)

Stock Owned through IRA Rollover Account

Stock Owned through IRA

 

Rollover Account

Stock Options

(Spouse)

Bonds in IRA

Leslie Hayes, MD

None

 

 

Carla Marienfield, MD

None

 

 

Ricardo Restrepo, MD, MPH

None

 

 

Richard Ries, MD, DFASAM

None

 

 

Edwin A. Salsitz, MD, DFASAM

None

 

 

Sharon Stancliff, MD

None

 

 

Timothy J. Wiegand, MD, FACMT, FAACT, FASAM

None

 

 

Erin Zerbo, MD

None

 

 

ACCME Accreditation Statement:

The American Society of Addiction Medicine is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Academy of Family Physicians: 

This Live activity, The 2017 ASAM Review Course in Addiction Medicine & Pre-Courses, with a beginning date of 07/26/2017, has been reviewed and is acceptable for up to 27.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABAM Transitional Maintenance of Certification Program (Tmoc)

This course has been approved by The American Board of Addiction Medicine (ABAM).  Physicians enrolled in the Transitional Maintenance of Certification (Tmoc) Program can apply a maximum of 20.5 AMA PRA Category 1 Credits

Upon completion, participants should be able to:

  • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
  • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
  • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
  • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
  • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

The ASAM Review Course in Addiction Medicine provides an up-to-date review of the core content of addiction medicine for:

  • Physicians preparing for the ABPM Board Certification/Recertification Examination in addiction medicine
  • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
  • Non-specialist physicians and other healthcare professionals needing the knowledge to identify and manage problems related to substance use disorders for their patients